Markets:

Overview

News

Currencies

International

Treasuries

Instil Bio, Inc. (NQ:TIL)

7.190 +0.110 (+1.55%)

Streaming Delayed Price Updated: 10:00 AM EST, Jan 22, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Instil Bio, Inc.

< Previous 1 2 3 4 Next >

On Thursday, there are stocks with unusual volume. Let's take a look. ↗

January 08, 2026

Via Chartmill

Unusual volume stocks in Wednesday's session ↗

January 07, 2026

Via Chartmill

Instil Bio Posts Wider Loss in Q2 ↗

August 13, 2025

Via The Motley Fool

Topics Intellectual Property

Here are the top movers in Monday's session. ↗

July 07, 2025

Let's have a look at what is happening on the US markets in the middle of the day on Monday. Below you can find the top gainers and losers in today's session.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

July 02, 2025

Via Benzinga

TIL Stock Earnings: Instil Bio Beats EPS for Q2 2024 ↗

August 13, 2024

TIL stock results show that Instil Bio beat analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Monday's After-Market Session ↗

June 02, 2025

Via Benzinga

These stocks are moving in today's after hours session ↗

June 02, 2025

Discover the top movers in Monday's after-hours session and stay informed about the post-market dynamics.

Via Chartmill

These stocks that are showing activity before the opening bell on Monday. ↗

June 02, 2025

Let's have a look at what is happening on the US markets before the opening bell on Monday. Below you can find the top gainers and losers in today's pre-market session.

Via Chartmill

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

June 02, 2025

Via Benzinga

Keep an eye on the top gainers and losers in Thursday's session. ↗

May 22, 2025

Stay up-to-date with the latest market trends one hour before the close of the markets on Thursday. Explore the top gainers and losers during today's session in our detailed report.

Via Chartmill

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

May 22, 2025

Via Benzinga

These stocks are moving in today's session ↗

May 22, 2025

Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements.

Via Chartmill

What's going on in today's pre-market session ↗

May 20, 2025

Wondering what's happening in Tuesday's pre-market session? Find an overview in this article.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

May 20, 2025

Via Benzinga

Why Pegasystems Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket ↗

May 20, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

April 25, 2025

Via Benzinga

Bullish Outlook On Instil Bio's Investigational Cancer Drug: Jefferies Sees Over 300% Stock Upside ↗

January 07, 2025

Jefferies upgrades Instil Bio to "Buy" with a $52 target, anticipating significant growth for PD-(L)1xVEGF class and SYN2510's potential in cancer treatments.

Via Benzinga

Up Over 600% in 2024, Can Summit Therapeutics Stock Keep Rising? ↗

October 24, 2024

This drugmaker's lead candidate could become a top-selling cancer therapy.

Via The Motley Fool

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

October 08, 2024

Via Benzinga

2 Stocks Up Over 700% in 2024 That Could Soar Even Further ↗

September 25, 2024

These relatively small companies are developing new cancer therapies that could generate billions in annual sales.

Via The Motley Fool

Steelcase Reports Weak Sales, Joins American Healthcare REIT And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

September 19, 2024

Via Benzinga

Sky Harbour Group, SolarEdge Technologies And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

September 17, 2024

Via Benzinga

Here's Why Everyone's Talking About Summit Therapeutics ↗

September 17, 2024

Find out why positive results from a Summit Therapeutics study keep pushing up BioNTech and Instil Bio stock.

Via The Motley Fool

Crude Oil Surges Over 1%; Instil Bio Shares Plunge ↗

September 16, 2024

Via Benzinga

iTeos Therapeutics, Upstart Holdings And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

September 16, 2024

Via Benzinga

Up More Than 500% in 2024. Can Instil Bio Keep Rocketing Higher? ↗

September 14, 2024

A candidate that Instil Bio in-licensed this August is similar to a candidate that recently outperformed the world's top-selling cancer therapy.

Via The Motley Fool

Exact Sciences To Rally Around 33%? Here Are 10 Top Analyst Forecasts For Thursday ↗

September 12, 2024

Via Benzinga

Week In Review: ImmuneOnco Out-Licenses Two Antibodies In $2 Billion Deal ↗

August 03, 2024

Shanghai ImmuneOnco Biopharma out-licensed global rites (ex-China) for two of its antibodies to Instil Bio of Dallas, Texas. ImmuneOnco will receive an upfront and near-term payments of $50 million,...

Via Talk Markets

Why ASP Isotopes Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

July 12, 2024

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.